黑色素性色素沉着疾病管理的全球共识
该全球共识由来自非洲、亚洲、欧洲和美洲的10位皮肤病学与色素性疾病专家制定,基于文献综述和结构化德尔菲流程,针对黄褐斑、炎症后色素沉着等常见黑色素性色素沉着疾病提出共识声明和分层治疗算法,强调广谱光防护和个体化治疗。
要点
- 管理需针对不同亚型和色素深度分层选择外用、系统或程序性治疗
- 广谱光防护是核心,但需关注有色防晒剂可及性挑战
- 治疗应兼顾黑素细胞及周围微环境如成纤维细胞、肥大细胞和血管成分
核心结论
- 共识为黑色素性色素沉着疾病提供全球适用的诊断和管理框架,强调个体化方法。
研究设计与样本
- 10位来自非洲、亚洲、欧洲和美洲的皮肤病学与色素性疾病专家参与制定。
- 基于全面文献综述和结构化德尔菲流程形成共识声明和治疗算法。
主要发现
- 常见黑色素性色素沉着疾病包括黄褐斑、炎症后色素沉着、获得性真皮斑状色素沉着、眶周色素沉着、慢性光损伤性色素沉着、雀斑/晒斑和皱褶部位色素沉着。
- 治疗选择涵盖外用美白剂、系统治疗(如口服氨甲环酸)和程序性干预(如化学剥脱、激光和IPL),按疾病亚型和色素深度分层。
- 共识强调有效管理需关注黑素细胞及周围皮肤微环境,包括成纤维细胞、肥大细胞和血管成分。
关键数值与推荐
- 治疗算法考虑皮肤类型、光生物学行为、疾病严重程度和区域治疗可及性。
- 特别强调广谱光防护的作用以及不同人群中着色防晒霜可及性的挑战。
临床怎么用
- 临床中应根据疾病亚型、色素深度和患者皮肤类型选择分层治疗策略。
- 管理应超越黑素细胞,综合考虑皮肤微环境因素。
- 需重视广谱光防护并解决着色防晒霜的可及性问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Melanin hyperpigmentation disorders (MHD) are among the most prevalent dermatologic concerns globally, affecting individuals across all skin phototypes and geographies. Despite their widespread impact on quality of life-including stigmatization, anxiety and depression-comprehensive, unified and practical clinical guidelines are lacking. This global consensus project convened 10 leading dermatologists and pigmentary disorder experts from Africa, Asia, Europe and the Americas to develop an evidence-based, internationally applicable framework for the management of common MHD, including melasma, post-inflammatory hyperpigmentation, acquired dermal macular hyperpigmentation, periorbital hyperpigmentation, chronic hyperpigmentary photodamage, freckles/ephelides and hyperpigmentation of the folds. Based on a comprehensive literature review and a structured Delphi process, the expert panel formulated consensus statements and tailored treatment algorithms that account for skin type, photobiological behaviour, disease severity and regional access to therapies. Special emphasis was placed on the role of broad-spectrum photoprotection and the challenges of tinted sunscreen availability in diverse populations. Treatment options ranged from topical lightening agents and systemic therapies (e.g. oral tranexamic acid) to procedural interventions (e.g. chemical peels, lasers and IPL) stratified by disease subtype and pigmentation depth. Notably, the consensus highlights that effective MHD management must address not only melanocytes but also the surrounding skin microenvironment, including fibroblasts, mast cells and vascular components. This consensus provides a globally adaptable clinical guide for the diagnosis and management of MHD, emphasizing a personalized approach that bridges scientific rigour with real-world applicability across diverse populations and health systems.
引用
- Passeron T, Desai SR, Abdallah M, et al. Global consensus on the management of melanin hyperpigmentation disorders. J Eur Acad Dermatol Venereol. 2025. PMID: 41362125. doi:10.1111/jdv.70185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。